Abbreviations

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov.

Cover of Clinical Review Report: Dexamethasone (Ozurdex)

Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].

Show details

Contents

< Prev Next >

Abbreviations

A1C: glycated hemoglobin
AE: adverse event
ANCOVA: analysis of covariance
ANOVA: analysis of variance
ATE: arterial thrombotic event
AUC: area under the curve
BCVA: best-corrected visual acuity
BRVO: branch retinal vein occlusion
CCB: Canadian Council of the Blind
CDR: CADTH Common Drug Review
CI: confidence interval
CNIB: Canadian National Institute for the Blind
CRT: central retinal thickness
DME: diabetic macular edema
DR: diabetic retinopathy
EQ-5D: EuroQol 5-Dimensions Health Questionnaire
ETDRS: Early Treatment Diabetic Retinopathy Study
FFB: Foundation Fighting Blindness
IDC: indirect comparison
IOP: intraocular pressure
ITT: intention to treat
IVRS: Interactive Voice Response System
IWRS: Interactive Web Response System
LOCF: last observation carried forward
LS: least squares
MCID: minimally clinically important difference
NA: not available
NEI-VFQ-25: National Eye Institute Visual Functioning Questionnaire-25
NICE: National Institute for Health and Care Excellence
NR: not reported
OCT: optical coherence tomography
PP: per-protocol
SAE: serious adverse event
SD: standard deviation
SF-36: Short Form (36) Health Survey
SD-OCT: spectral domain optical coherence tomography
TD-OCT: time domain optical coherence tomography
VEGF: vascular endothelial growth factor
WDAE: withdrawal due to adverse event

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK539254

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov. Abbreviations.
PDF version of this title (2.0M)

Other titles in this collection

CADTH Common Drug Reviews

Recent Activity

Clear Turn Off Turn On

Abbreviations - Clinical Review Report: Dexamethasone (Ozurdex)
Abbreviations - Clinical Review Report: Dexamethasone (Ozurdex)

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].

Abbreviations

Views

Other titles in this collection

Recent Activity